• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤中的巨噬细胞:一把双刃剑及靶向治疗策略(综述)

Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review).

作者信息

Zhou Qiujun, Fang Tingting, Wei Shenyu, Chai Shiqian, Yang Huifeng, Tao Maocan, Cao Yi

机构信息

Department of First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310000, P.R. China.

Department of Hepato-Pancreato-Biliary Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, P.R. China.

出版信息

Exp Ther Med. 2022 Aug 26;24(4):640. doi: 10.3892/etm.2022.11577. eCollection 2022 Oct.

DOI:10.3892/etm.2022.11577
PMID:36160877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9468802/
Abstract

Melanoma, which evolves from melanocytes, is the most malignant skin cancer and is highly fatal, although it only accounts for 4% of all skin cancers. Numerous studies have demonstrated that melanoma has a large tumor mutational burden, which means that melanoma has great potential to achieve immune evasion. Tumor-associated macrophages (TAMs) are an important component of both the immune system and tumor microenvironment. Several studies have demonstrated their double-edged sword effects on melanoma. The present review focuses on the role of TAMs in melanoma development, including regulation of proliferation, invasion, metastasis, angiogenesis and chemical resistance of melanoma. Furthermore, the existing mechanisms of action of the TAM-targeting treatments for melanoma are reviewed. More broadly, the weak points of existing research and the direction of future research are finally identified and described.

摘要

黑色素瘤起源于黑素细胞,是最恶性的皮肤癌,致死率很高,尽管它仅占所有皮肤癌的4%。大量研究表明,黑色素瘤具有很高的肿瘤突变负荷,这意味着黑色素瘤具有很强的免疫逃逸潜力。肿瘤相关巨噬细胞(TAM)是免疫系统和肿瘤微环境的重要组成部分。多项研究表明它们对黑色素瘤具有双刃剑效应。本综述重点关注TAM在黑色素瘤发展中的作用,包括对黑色素瘤增殖、侵袭、转移、血管生成和化学抗性的调节。此外,还综述了针对黑色素瘤的TAM靶向治疗的现有作用机制。更广泛地说,最终确定并描述了现有研究的薄弱点和未来研究的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9468802/b747e6a93ad9/etm-24-04-11577-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9468802/7fa9956cd86c/etm-24-04-11577-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9468802/b747e6a93ad9/etm-24-04-11577-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9468802/7fa9956cd86c/etm-24-04-11577-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9468802/b747e6a93ad9/etm-24-04-11577-g01.jpg

相似文献

1
Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review).黑色素瘤中的巨噬细胞:一把双刃剑及靶向治疗策略(综述)
Exp Ther Med. 2022 Aug 26;24(4):640. doi: 10.3892/etm.2022.11577. eCollection 2022 Oct.
2
The role of tumor-associated macrophage in breast cancer biology.肿瘤相关巨噬细胞在乳腺癌生物学中的作用。
Histol Histopathol. 2018 Feb;33(2):133-145. doi: 10.14670/HH-11-916. Epub 2017 Jul 6.
3
Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells.巨噬细胞是一把双刃剑:肿瘤相关巨噬细胞与癌症干细胞之间的分子串扰。
Biomolecules. 2022 Jun 19;12(6):850. doi: 10.3390/biom12060850.
4
Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.基于 M2 样肿瘤相关巨噬细胞靶向纳米复合物的肿瘤微环境重塑与肿瘤治疗。
Theranostics. 2021 Jan 1;11(6):2892-2916. doi: 10.7150/thno.50928. eCollection 2021.
5
NFAT1 enhances the effects of tumor-associated macrophages on promoting malignant melanoma growth and metastasis.NFAT1 增强肿瘤相关巨噬细胞促进恶性黑色素瘤生长和转移的作用。
Biosci Rep. 2018 Dec 18;38(6). doi: 10.1042/BSR20181604. Print 2018 Dec 21.
6
Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.通过重编程肿瘤相关巨噬细胞开发的基于纳米医学的癌症免疫疗法。
Nanoscale. 2021 Mar 12;13(9):4705-4727. doi: 10.1039/d0nr08050k.
7
Melanoma-Derived Exosomal miR-125b-5p Educates Tumor Associated Macrophages (TAMs) by Targeting Lysosomal Acid Lipase A (LIPA).黑色素瘤来源的外泌体miR-125b-5p通过靶向溶酶体酸性脂肪酶A(LIPA)来塑造肿瘤相关巨噬细胞(TAM)。
Cancers (Basel). 2020 Feb 17;12(2):464. doi: 10.3390/cancers12020464.
8
Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers.肿瘤相关巨噬细胞失调在妇科和乳腺癌的发生、发展及靶向治疗中的作用。
J Hematol Oncol. 2021 Oct 30;14(1):181. doi: 10.1186/s13045-021-01198-9.
9
Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.肿瘤相关巨噬细胞通过自分泌和旁分泌方式以肾上腺髓质素促进血管生成和黑色素瘤生长。
Clin Cancer Res. 2011 Dec 1;17(23):7230-9. doi: 10.1158/1078-0432.CCR-11-1354. Epub 2011 Oct 12.
10
Targeting Tumor-Associated Macrophages in Cancer Immunotherapy.癌症免疫治疗中靶向肿瘤相关巨噬细胞
Cancers (Basel). 2021 Oct 22;13(21):5318. doi: 10.3390/cancers13215318.

引用本文的文献

1
Targeting TAMs & CAFs in melanoma: New approaches to tumor microenvironment therapy.靶向黑色素瘤中的肿瘤相关巨噬细胞和癌相关成纤维细胞:肿瘤微环境治疗的新方法
Oncol Res. 2025 Aug 28;33(9):2221-2242. doi: 10.32604/or.2025.064677. eCollection 2025.
2
Anti-PD-1 treatment response is associated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment.抗程序性死亡蛋白1(Anti-PD-1)治疗反应与循环髓系细胞和T细胞亚群流入转移性黑色素瘤肿瘤微环境有关。
Br J Cancer. 2025 Sep 2. doi: 10.1038/s41416-025-03137-8.
3
Davanat-Mimetic Galactomannan and Its Sulfated Derivative: Structure and Antitumor Effects against Melanoma.

本文引用的文献

1
Cellular Carcinogenesis: Role of Polarized Macrophages in Cancer Initiation.细胞癌变:极化巨噬细胞在癌症起始中的作用
Cancers (Basel). 2022 Jun 6;14(11):2811. doi: 10.3390/cancers14112811.
2
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors.工程化 CAR-巨噬细胞作为实体瘤的过继免疫疗法。
Front Immunol. 2021 Nov 24;12:783305. doi: 10.3389/fimmu.2021.783305. eCollection 2021.
3
Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO.巨噬细胞重编程与癌症治疗学:iNOS 衍生的 NO 的作用。
达瓦纳特模拟半乳甘露聚糖及其硫酸化衍生物:结构与对黑色素瘤的抗肿瘤作用
Biomacromolecules. 2025 Sep 8;26(9):5614-5632. doi: 10.1021/acs.biomac.5c00290. Epub 2025 Aug 21.
4
A Consolidated Review of Contemporary Targeted and Immunotherapeutic Options for Melanoma.黑色素瘤当代靶向治疗和免疫治疗选择的综合综述
Biomedicines. 2025 Jun 5;13(6):1388. doi: 10.3390/biomedicines13061388.
5
Macrophage-derived Fgl2 dampens antitumor immunity through regulation of FcγRIIB+CD8+ T cells in melanoma.巨噬细胞衍生的Fgl2通过调节黑色素瘤中FcγRIIB + CD8 + T细胞来抑制抗肿瘤免疫。
JCI Insight. 2025 Mar 24;10(6):e182563. doi: 10.1172/jci.insight.182563.
6
Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets.癌症中巨噬细胞衍生的长链非编码RNA:肿瘤进展的调节因子和治疗靶点。
Med Oncol. 2025 Mar 6;42(4):91. doi: 10.1007/s12032-025-02643-2.
7
Melanoma-derived extracellular vesicles transfer proangiogenic factors.黑色素瘤来源的细胞外囊泡可传递促血管生成因子。
Oncol Res. 2025 Jan 16;33(2):245-262. doi: 10.32604/or.2024.055449. eCollection 2025.
8
New Insights into Aspirin's Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites.阿司匹林抗癌活性的新见解:其铁螯合抗氧化代谢产物的主要作用
Antioxidants (Basel). 2024 Dec 29;14(1):29. doi: 10.3390/antiox14010029.
9
Patient-Derived Melanoma Immune-Tumoroids as a Platform for Precise High throughput Drug Screening.患者来源的黑色素瘤免疫肿瘤样物作为精确高通量药物筛选的平台
Adv Sci (Weinh). 2024 Dec;11(48):e2408707. doi: 10.1002/advs.202408707. Epub 2024 Oct 30.
10
Morphological and Immunohistochemical Aspects with Prognostic Implications and Therapeutic Targets of Primary Sinonasal Mucosal Melanoma: A Retrospective Study.原发性鼻窦黏膜黑色素瘤的形态学和免疫组织化学特征及其预后意义和治疗靶点:一项回顾性研究
Cancers (Basel). 2024 Aug 16;16(16):2863. doi: 10.3390/cancers16162863.
Cells. 2021 Nov 16;10(11):3194. doi: 10.3390/cells10113194.
4
Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages.髓源性抑制细胞扩增通过抑制巨噬细胞中 CD40/IL27 的调节促进黑色素瘤生长和自身免疫。
Cancer Res. 2021 Dec 1;81(23):5977-5990. doi: 10.1158/0008-5472.CAN-21-1148. Epub 2021 Oct 12.
5
Endostatin inhibits the proliferation and migration of B16 cells by inducing macrophage polarity to M1‑type.内皮抑素通过诱导巨噬细胞极性向 M1 型转变来抑制 B16 细胞的增殖和迁移。
Mol Med Rep. 2021 Dec;24(6). doi: 10.3892/mmr.2021.12481. Epub 2021 Oct 11.
6
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.免疫检查点阻断的反应、耐药和毒性的特征。
Cell. 2021 Oct 14;184(21):5309-5337. doi: 10.1016/j.cell.2021.09.020. Epub 2021 Oct 7.
7
Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model.阻断 TGF-βR 通过调节肿瘤细胞迁移能力和影响黑色素瘤模型中的免疫细胞来提高多柔比星的疗效。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Nov;394(11):2309-2322. doi: 10.1007/s00210-021-02134-x. Epub 2021 Sep 9.
8
Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment.肿瘤内体TLR通路的激活揭示了TLR3激动剂依赖性1型干扰素在塑造肿瘤免疫微环境中的独特作用。
Front Oncol. 2021 Jul 26;11:711673. doi: 10.3389/fonc.2021.711673. eCollection 2021.
9
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.CpG-A Toll 样受体 9 激动剂 Vidutolimod 克服转移性黑色素瘤患者的 PD-1 阻断耐药性。
Cancer Discov. 2021 Dec 1;11(12):2998-3007. doi: 10.1158/2159-8290.CD-21-0425.
10
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.《全国癌症状况年度报告》第 1 部分:国家癌症统计。
J Natl Cancer Inst. 2021 Nov 29;113(12):1648-1669. doi: 10.1093/jnci/djab131.